These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30431206)

  • 1. Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma.
    Liu YQ; Chai RC; Wang YZ; Wang Z; Liu X; Wu F; Jiang T
    Cancer Sci; 2019 Jan; 110(1):321-333. PubMed ID: 30431206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
    Qi Y; Chen D; Lu Q; Yao Y; Ji C
    Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a mesenchymal-related signature associated with clinical prognosis in glioma.
    Zhang Z; Chen J; Huo X; Zong G; Huang K; Cheng M; Sun L; Yue X; Bian E; Zhao B
    Aging (Albany NY); 2021 Apr; 13(9):12431-12455. PubMed ID: 33875619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
    Xu J; Liu F; Li Y; Shen L
    Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication.
    Fan Y; Peng X; Li B; Zhao G
    Biomed Res Int; 2020; 2020():1872962. PubMed ID: 32964017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.
    Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW
    Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients.
    Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L
    Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying lower grade glioma cases according to whole genome gene expression.
    Chen B; Liang T; Yang P; Wang H; Liu Y; Yang F; You G
    Oncotarget; 2016 Nov; 7(45):74031-74042. PubMed ID: 27677590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
    Zeng F; Wang K; Liu X; Zhao Z
    Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
    Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
    Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.
    Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T
    CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
    Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
    World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
    Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.